Skip to main content
AmigoFish

Top Takeaways from ACC.26

From Eagle's Eye View: Your Weekly CV Update From ACC.org · · 11 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

In this week's View, Dr. Eagle highlights trials from the recently held ACC Scientific Sessions which took place in New Orleans, March 28-30. Important studies discussed include:

- CHAMPION-AF: Left atrial appendage closure vs. anticoagulation for AFib

- VESALIUS-CV: Evolocumab reduces CV risk in diabetic patients without ASCVD

- Ez-PAVE: Hitting lower LDL-C target reduces major CV events

- PRO-TAVI: Should high-risk patients undergo PCI before TAVI?

- SMART-DECISION: Discontinuing beta-blockers safe 1 year post MI For stable patients

- GoFreshRx: How home-delivered DASH groceries improve blood pressure (BP) and LDL-C

- THRIVE: Exploring the positive effects of a culturally tailored "food-is medicine" program on lowering BP

Back to Eagle's Eye View: Your Weekly CV Update From ACC.org · Report a problem